P&G's Personal Health Sector Has Merck Consumer Chief As International Head
Executive Summary
P&G names Merck KGAA consumer chief Uta Kemmerich-Keil to lead international division of personal health business as it closes on $4.2bn acquisition of German firm's consumer business. Deal closes a month after P&G announced biggest changes to organizational structure in 20 years, including combining personal care and health care into personal health and forming six global units, each headed by a CEO.
You may also be interested in...
Merck KGaA Tightens Focus With Allergopharma Sale
Germany’s family-controlled big pharma, Merck KGaA, is divesting its allergens business, Allergopharma to the fast-growing Munich healthcare company, Dermapharm Holding.
P&G Broad-Based Beauty Business Bounce Behind 4% Overall Sales Growth
P&G reported total beauty division sales grew 5% to $3.29bn, with a 20% jump in SK-II offset somewhat by low single-digit growth in hair care. Investors rewarded the firm’s better-than-expected net sales results with same-day 9% bump in its share price.
P&G Adds Merck's Brands, Expands Consumer Health Categories, Footprint
P&G’s planned acquisition of Merck KGaA’s consumer health care business will grow its consumer health portfolio 50%, expand its OTC drug and supplement business abroad and open up new categories. CEO David Taylor frames the acquisition as another step in the firm's ongoing portfolio shakeup.